Cargando…

The haemodynamic assessment of patients with pulmonary arterial hypertension

Detalles Bibliográficos
Autor principal:	Ghio, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Magdi Yacoub Heart Foundation 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590935/ https://www.ncbi.nlm.nih.gov/pubmed/33150149 http://dx.doi.org/10.21542/gcsp.2020.4

Ejemplares similares

Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy
por: Ghio, Stefano, et al.
Publicado: (2016)

Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
por: Sitbon, Olivier, et al.
Publicado: (2014)

Chronic Thromboembolic Pulmonary Hypertension: Treat the Patient Not the Haemodynamics
por: Dunne, Ben, et al.
Publicado: (2012)

Response to acute vasodilator challenge and haemodynamic modifications after MitraClip in patients with functional mitral regurgitation and pulmonary hypertension
por: Mandurino-Mirizzi, Alessandro, et al.
Publicado: (2022)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Contrasting haemodynamic effects of exercise and saline infusion in older adults with pulmonary arterial hypertension
por: Valle, Felipe H., et al.
Publicado: (2021)

Haemodynamic definitions and updated clinical classification of pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2019)

Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis
por: Slivnick, Jeremy, et al.
Publicado: (2022)

Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms
por: Lunardi, Mattia, et al.
Publicado: (2022)

Longitudinal strain correlated with haemodynamics in patients with chronic thromboembolic pulmonary hypertension
por: Liu, Min, et al.
Publicado: (2016)

Haemodynamics of Hypertension in Children
por: Li, Ye, et al.
Publicado: (2020)

Parameter inference in a computational model of haemodynamics in pulmonary hypertension
por: Colunga, Amanda L., et al.
Publicado: (2023)

Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Pulmonary arterial compliance: How and why should we measure it?
por: Ghio, Stefano, et al.
Publicado: (2015)

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2017)

Risk assessment in pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2016)

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients
por: Cavagna, Lorenzo, et al.
Publicado: (2016)

A haemodynamic conundrum: a case report of a patient with concurrent pulmonary arterial hypertension and hypertrophic obstructive cardiomyopathy
por: Hassanin, Ahmed, et al.
Publicado: (2021)

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
por: Kim, Nick H, et al.
Publicado: (2017)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease
por: Alhabeeb, Waleed, et al.
Publicado: (2014)

Haemodynamic and structural correlates of the first and second heart sounds in pulmonary arterial hypertension: an acoustic cardiography cohort study
por: Chan, William, et al.
Publicado: (2013)

Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hypertension patients scheduled for pulmonary thromboendarterectomy. Is schistosomiasis hypertension an important confounding factor?
por: Terra‐Filho, Mario, et al.
Publicado: (2010)

A meta-analysis of the haemodynamics of primary hypertension in children and adults
por: Li, Ye, et al.
Publicado: (2023)

The Evolution of Risk Assessment in Pulmonary Arterial Hypertension
por: Murthy, Sandhya, et al.
Publicado: (2021)

Safety and feasibility of obtaining wedged pulmonary artery samples and differential distribution of biomarkers in pulmonary hypertension
por: Fares, Wassim H., et al.
Publicado: (2012)

Galectin-3 Plasma Levels Are Associated with Risk Profiles in Pulmonary Arterial Hypertension
por: Scelsi, Laura, et al.
Publicado: (2020)

Assessment of right ventricle in pulmonary arterial hypertension with three-dimensional echocardiography and cardiovascular magnetic resonance
por: Lattanzio, Mariangela, et al.
Publicado: (2021)

Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension
por: Hennigs, Jan K., et al.
Publicado: (2014)

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial
por: Ehlken, Nicola, et al.
Publicado: (2016)

The Evolving Concepts of Haemodynamic Support: From Pulmonary Artery Catheter to Echocardiography and Theragnostics
por: Figueiredo, Antonio, et al.
Publicado: (2011)

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability
por: Revuz, Sabine, et al.
Publicado: (2017)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Assessment of Pulmonary Arterial Hypertension by Magnetic Resonance Imaging
por: Ibrahim, El-Sayed H., et al.
Publicado: (2015)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension
por: Ghio, Stefano, et al.
Publicado: (2017)

Acute and short-term haemodynamic effect of Sildenafil in pulmonary hypertension: Egyptian pilot study of seven patients
por: Zaki, S, et al.
Publicado: (2004)

Non-Invasive Assessment of Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Dara, Athanasia, et al.
Publicado: (2021)

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
por: Russo, Elisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9jfursod74f7ea8aj1nnug1t4n